Prosaposin and cytokine-derived peptides as therapeutic agents
Details for Australian Patent Application No. 2010200055 (hide)
International Classifications
Event Publications
21 January 2010 Complete Application Filed
28 January 2010 Application Open to Public Inspection
Published as AU-B-2010200055
27 May 2010 Section 223 Application Received
The Regents of the University of California; Myelos Corporation An application to extend the time from 07 Feb 2009 to 07 Jan 2010 in which to make a further application for a divisional patent has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
15 July 2010 Section 223 Application Allowed
The Regents of the University of California; Myelos Corporation The time in which to make a further application for a divisional patent has been extended to 07 Jan 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
29 March 2012 Application Accepted
Published as AU-B-2010200055
26 July 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 25 Jun 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2011
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010200056-Dendrimer based compositions and methods of using the same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser